Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action
References (72)
- et al.
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
Lancet
(1989) - et al.
Hepatitis B virus infection without immunological markers after open-heart surgery
Lancet
(1995) - et al.
Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues
J Hepatol
(1997) - et al.
A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC study
Hepatology
(1997) - et al.
Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
Hepatology
(1995) - et al.
Post-transfusional anti-HCV negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses
J Hepatol
(1993) - et al.
Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA
J Hepatol
(1996) - et al.
Hepatitis C virus antibody and hepatocellular carcinoma
Lancet
(1990) - et al.
Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus
J Hepatol
(1995) - et al.
Transmission of hepatitis B from seronegative subjects
Lancet
(1988)
“Occult” hepatitis B virus as source of infection in liver transplant recipients
Lancet
(1994)
A unique insertion in the S gene of surface antigen negative hepatitis B virus Chinese carriers
Hepatology
(1995)
Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient
J Hepatol
(1993)
Precore/core mutations of hepatitis B virus in hepatocellular carinomas developed on noncirrhotic livers
Gastroenterology
(1996)
Effects of ethanol on hepatitis B virus PRE/S/S genes expression in the human hepatocellular carcinoma derived HepG2 cell line
J Hepatol
(1995)
Presence of antibodies to the hepatitis B surface antigen associated with an excess risk for hepatocellular crcnoma among non-Asians in Los Angeles county, California
Hepatology
(1997)
HCV-associated hepatocellular carcinoma without cirrhosis
J Hepatol
(1996)
Clinical and virological profiles in patients with multiple hepatitis virus infections
Gastroenterology
(1993)
Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications
J Hepatol
(1987)
Role of cirrhosis in hepatocarcinogenesis
Hepatocellular carcinoma: recent progress
Hepatology
(1992)
Hepatocellular carcinoma
J Hepatol
(1992)
Hepatitis C virus infection and hepatocellular carcinoma
Hepatitis B virus and primary liver cancer in hepatitis B surface antigen-positive and negative patients
Hepatitis C virus as a causative agent of hepatocellular carcinoma
Intervirology
(1995)
Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma
J Hepatol
(1996)
Hepatitis C virus biology and genetic variability: implications for the management of infected patients
A case-control study of hepatitis B and C virus infections in the etiolgy of hepatocellular carcinoma
Int J Cancer
(1995)
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
J Hepatol
(1997)
Molecular mechanisms of hepatitis B and C viruses related liver carcinogenesis
Hepatitis B and C viral infections in patients with hepatocellular carcinoma
Hepatology
(1992)
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
Cancer
(1991)
Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen
N Engl J Med
(1985)
Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer
FEMS Letter
(1991)
X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis
J Infect Dis
(1995)
Viral pathogenesis of hepatocellular carcinoma in the United States
Hepatology
(1993)
Cited by (149)
A critical review on quercetin bioflavonoid and its derivatives: Scope, synthesis, and biological applications with future prospects
2023, Arabian Journal of ChemistryHighly sensitive plasmonic biosensor for hepatitis B virus DNA based on the surface etching of the active helical gold nanorods
2023, Chemical Engineering Journal“Hepatitis virus indicator”—-the simultaneous detection of hepatitis B and hepatitis C viruses based on the automatic particle enumeration
2022, Biosensors and BioelectronicsHepatitis B and cancer: A practical guide for the oncologist
2016, Critical Reviews in Oncology/HematologyInfluence of hepatitis viruses on clinico-pathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma
2014, Hepatobiliary and Pancreatic Diseases InternationalAnti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
2014, Annals of HepatologyCitation Excerpt :The development of sensitive assays to detect small amounts of HBV DNA has favored the identification of occult hepatitis B infection, which is characterized by undetectable HBsAg in serum and HBV DNA detectable in the liver tissue.11 In patients with chronic hepatitis C, occult HBV infection was found to be associated with more severe liver damage,12,13 a higher risk of developing HCC14–19 and HBV reactivation in immunosuppressed patients,20,21 such as onco-hematological patients receiving chemotherapy.22 This virological condition has been more frequently found in patients with serological markers of previous HBV infection (anti-HBc, anti-HBs) than in those without.23
Copyright © 1998 Published by Elsevier Ireland Ltd.